CST3 and chronic kidney disease: Cystatin C has been reported as a better biomarker in Africa but is rarely used because it is expensive [67] and none of the studies included used Cystatin C. One of the studies used UNGAL as the biomarker, this has shown promise for early diagnosis of CKD as it is elevated before decline in eGFR and development of albuminuria [68].